We are live on ! Find out more
NFSG

Newbridge Financial Services Group Portfolio holdings

AUM $608M
1-Year Est. Return 31.28%
This Fund
S&P 500
This Quarter Est. Return
-1.5%
1 Year Est. Return
+31.28%
3 Year Est. Return
+114.56%
5 Year Est. Return
+128.99%
10 Year Est. Return
AUM
$160M
AUM Growth
-$3.21M
Cap. Flow
+$2.59M
Cap. Flow %
1.62%
Top 10 Hldgs %
24.05%
Holding
1,688
New
185
Increased
386
Reduced
324
Closed
322

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.53M
2
SENS icon
Senseonics Holdings Inc
SENS
+$732K
3
BABA icon
Alibaba
BABA
+$700K
4
FDX icon
FedEx
FDX
+$611K
5
BA icon
Boeing
BA
+$606K

Sector Composition

Rank Sector Weight
1 Technology 25.6%
2 Consumer Discretionary 14.12%
3 Healthcare 7.56%
4 Communication Services 5.84%
5 Financials 5.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESML icon
1176
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.89B
$2K ﹤0.01%
50
HCAT icon
1177
Health Catalyst
HCAT
$171M
$2K ﹤0.01%
34
ICLN icon
1178
iShares Global Clean Energy ETF
ICLN
$2.37B
$2K ﹤0.01%
100
ICUI icon
1179
ICU Medical
ICUI
$4.16B
$2K ﹤0.01%
10
INSM icon
1180
Insmed
INSM
$28.7B
$2K ﹤0.01%
79
JNK icon
1181
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.91B
$2K ﹤0.01%
21
KGC icon
1182
Kinross Gold
KGC
$30.4B
$2K ﹤0.01%
307
KIE icon
1183
State Street SPDR S&P Insurance ETF
KIE
$645M
$2K ﹤0.01%
54
+1
+2% +$39
KPRX icon
1184
Kiora Pharmaceuticals
KPRX
$11.3M
$2K ﹤0.01%
3
LDOS icon
1185
Leidos
LDOS
$17B
$2K ﹤0.01%
+16
New +$1.59K
LIN icon
1186
Linde
LIN
$226B
$2K ﹤0.01%
8
NEO icon
1187
NeoGenomics
NEO
$2B
$2K ﹤0.01%
32
NI icon
1188
NiSource
NI
$20.8B
$2K ﹤0.01%
62
NYC
1189
American Strategic Investment Co
NYC
$27.4M
$2K ﹤0.01%
25
OGN icon
1190
Organon & Co
OGN
$3.56B
$2K ﹤0.01%
61
-75
-55% -$2.4K
OPK icon
1191
Opko Health
OPK
$985M
$2K ﹤0.01%
+500
New +$1.86K
PCTY icon
1192
Paylocity
PCTY
$8.39B
$2K ﹤0.01%
6
PRFZ icon
1193
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.84B
$2K ﹤0.01%
+55
New +$2.01K
PTPI
1194
DELISTED
Petros Pharmaceuticals
PTPI
$2K ﹤0.01%
5
BCIC
1195
BCP Investment Corp
BCIC
$91.5M
$2K ﹤0.01%
88
PXH icon
1196
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.95B
$2K ﹤0.01%
+105
New +$2.39K
RPRX icon
1197
Royalty Pharma
RPRX
$25.4B
$2K ﹤0.01%
50
SH icon
1198
ProShares Short S&P500
SH
$902M
$2K ﹤0.01%
30
SHV icon
1199
iShares 0-1 Year Treasury Bond ETF
SHV
$20.6B
$2K ﹤0.01%
17
SNPS icon
1200
Synopsys
SNPS
$77.7B
$2K ﹤0.01%
7
-1
-13% -$304

Similar funds

Newbridge Financial Services Group's Q3 2021 Portfolio in Review

As of Q3 2021, Newbridge Financial Services Group held 1,688 positions worth $160M, down 2% from $163M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Newbridge Financial Services Group's Q3 2021 filing shows 185 new, 386 increased, 324 reduced and 322 closed positions. Its largest new stake was Lemonade: 6,250 shares worth $419K. The largest sale was John Hancock Premium Dividend Fund, an estimated $986K.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Newbridge Financial Services Group's largest Q3 2021 buy was Lemonade: 6,250 shares worth $419K.
  • Newbridge Financial Services Group added most to Apple in Q3 2021, an estimated $1.53M increase.
  • Newbridge Financial Services Group's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $559K.
  • Newbridge Financial Services Group fully exited John Hancock Premium Dividend Fund in Q3 2021, selling an estimated $986K.
  • Newbridge Financial Services Group's ten largest holdings make up 24% of its $160M portfolio in Q3 2021.
  • Newbridge Financial Services Group opened 185 new positions and closed 322 in Q3 2021.
  • Newbridge Financial Services Group's portfolio value fell 2% quarter-over-quarter to $160M.

Based on Newbridge Financial Services Group's 13F filing for Q3 2021, filed 27 Oct 2021.